SPONSOR
Gracell Biotechnologies (Shanghai) Co., Ltd.
Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd. is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Multiple Myeloma.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Gracell Biotechnologies (Shanghai) Co., Ltd.
How many clinical trials has Gracell Biotechnologies (Shanghai) Co., Ltd. sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Gracell Biotechnologies (Shanghai) Co., Ltd., of which 1 are actively recruiting participants. These trials cover conditions including Multiple Myeloma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Gracell Biotechnologies (Shanghai) Co., Ltd. research focus on?
Gracell Biotechnologies (Shanghai) Co., Ltd. clinical trials span Multiple Myeloma. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Gracell Biotechnologies (Shanghai) Co., Ltd. clinical trial?
To participate in a Gracell Biotechnologies (Shanghai) Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Gracell Biotechnologies (Shanghai) Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Gracell Biotechnologies (Shanghai) Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology